These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29513966)

  • 21. The effect of binders on the bioavailability of ofloxacin tablets in animal model.
    Rasool F; Ahmad M; Khan HM; Akhtar N; Murtaza G
    Acta Pol Pharm; 2010; 67(2):185-9. PubMed ID: 20369796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bilayer Tablet Dissolution Kinetics Based on a Degassing Cyclic Flow UV-Vis Spectroscopy with Chemometrics.
    Otsuka Y; Ito A; Takahashi T; Matsumura S; Takeuchi M; Tanaka H
    Chem Pharm Bull (Tokyo); 2019; 67(4):361-366. PubMed ID: 30930440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of magnesium stearate concentration on dissolution properties of ranitidine hydrochloride coated tablets.
    Uzunović A; Vranić E
    Bosn J Basic Med Sci; 2007 Aug; 7(3):279-83. PubMed ID: 17848158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer.
    Liu F; Shokrollahi H
    Int J Pharm; 2015 May; 485(1-2):152-9. PubMed ID: 25746736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a Dissolution Method for Gliclazide Modified-Release Tablets Using USP Apparatus 3 with in Vitro-in Vivo Correlation.
    Bezerra KC; Pinto EC; Cabral LM; de Sousa VP
    Chem Pharm Bull (Tokyo); 2018; 66(7):701-707. PubMed ID: 29962453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet.
    Mourão SC; da Silva C; Bresolin TM; Serra CH; Porta V
    Int J Pharm; 2010 Feb; 386(1-2):201-7. PubMed ID: 19941944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereoselective determination of ofloxacin and its metabolites in human urine by capillary electrophoresis using laser-induced fluorescence detection.
    Horstkötter C; Blaschke G
    J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(1):169-78. PubMed ID: 11318412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Separation of ofloxacin enantiomers by high performance capillary electrophoresis(HPCE)].
    Liu X
    Yao Xue Xue Bao; 1998 Aug; 33(8):600-4. PubMed ID: 12016900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Continuous in situ monitoring of the dissolution rate of solid pharmaceutical preparations using a multiple channel fiber-optic chemical sensor].
    Zhang QM; Ge JH; Mai ED; Su QZ; Chen J
    Yao Xue Xue Bao; 2003 Apr; 38(4):294-7. PubMed ID: 12889132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biowaiver studies of Metronidazole tablets (400mg): An alternative to In-vivo bioequivalence Studies.
    Safdar KA; Naqvi SB; Usman S; Rehman S; Muhammad IN
    Pak J Pharm Sci; 2018 Nov; 31(6):2411-2418. PubMed ID: 30473512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Permeability assessment for solid oral drug formulations based on Caco-2 monolayer in combination with a flow through dissolution cell.
    Motz SA; Schaefer UF; Balbach S; Eichinger T; Lehr CM
    Eur J Pharm Biopharm; 2007 May; 66(2):286-95. PubMed ID: 17156983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous release of diclofenac sodium and papaverine hydrochloride from tablets and pellets using the flow-through cell apparatus described by dimensionless equations.
    Kasperek R
    Acta Pol Pharm; 2011; 68(2):261-72. PubMed ID: 21485300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781.
    Goddeeris C; Willems T; Van den Mooter G
    Eur J Pharm Sci; 2008 Aug; 34(4-5):293-302. PubMed ID: 18602800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl.
    Ali A; Iqbal M; Akhtar N; Khan HM; Ullah A; Uddin M; Khan MT
    Acta Pol Pharm; 2013; 70(2):283-9. PubMed ID: 23614284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissolution profile of 24 levofloxacin (100 mg) tablets.
    Maezawa K; Yajima R; Terajima T; Kizu J; Hori S
    J Infect Chemother; 2013 Oct; 19(5):996-8. PubMed ID: 23380968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemometrics-assisted spectrophotometric green method for correcting interferences in biowaiver studies: Application to assay and dissolution profiling study of donepezil hydrochloride tablets.
    Korany MA; Mahgoub H; Haggag RS; Ragab MAA; Elmallah OA
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Jun; 199():328-339. PubMed ID: 29627618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
    Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
    Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.